These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28780060)

  • 1. Correspondence regarding Castle., Human papillomavirus screening for low and middle-income countries.
    Suba EJ
    Prev Med; 2017 Dec; 105():357-358. PubMed ID: 28780060
    [No Abstract]   [Full Text] [Related]  

  • 2. Correspondence regarding Suba et al., human papillomavirus screening for low and middle-income countries.
    Castle PE
    Prev Med; 2017 Dec; 105():356. PubMed ID: 28939142
    [No Abstract]   [Full Text] [Related]  

  • 3. In response to: Human papillomavirus screening for low and middle-income countries.
    Schiffman M
    Prev Med; 2017 Jul; 100():297-298. PubMed ID: 28583663
    [No Abstract]   [Full Text] [Related]  

  • 4. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 5. [New guidelines in regard to cervical cancer screening].
    Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
    Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer prevention: new guidelines in the United States and new opportunities for low- and middle-income countries.
    Waxman AG
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):251-5. PubMed ID: 23732029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany.
    Petry KU; Barth C; Wasem J; Neumann A
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():132-139. PubMed ID: 28363186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus DNA and Pap tests: the need for cotesting in opportunistic setting during the transition time.
    Mariani L; Sideri M; Costa S; Cristoforoni P; Origoni M; Preti M;
    J Low Genit Tract Dis; 2013 Jul; 17(3):362-5. PubMed ID: 23552207
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing cervical cancer in the Latina population.
    Flores K; Bencomo C
    J Womens Health (Larchmt); 2009 Dec; 18(12):1935-43. PubMed ID: 20044855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus, current vaccines, and cervical cancer prevention.
    Teitelman AM; Stringer M; Averbuch T; Witkoski A
    J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
    Steele CB; Thomas CN; Richardson LC
    J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.
    Wong EL; Chan PK; Chor JS; Cheung AW; Huang F; Wong SY
    Cancer Nurs; 2016; 39(1):E1-E11. PubMed ID: 25730587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?
    Feldman S
    JAMA Intern Med; 2014 Oct; 174(10):1539-40. PubMed ID: 25069413
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV vaccination: effects on cervical screening.
    Kothari A
    Nurs Times; 2014 Jun 11-17; 110(24):19-21. PubMed ID: 25007499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus screening for low and middle-income countries.
    Suba EJ; Zarka MA; Raab SS
    Prev Med; 2017 Jul; 100():296. PubMed ID: 28583662
    [No Abstract]   [Full Text] [Related]  

  • 17. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
    Stoler MH
    J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 19. HPV, cervical cancer risks, and barriers to care for lesbian women.
    Waterman L; Voss J
    Nurse Pract; 2015 Jan; 40(1):46-53; quiz 53-4. PubMed ID: 25437384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.